Abbott: Cardiovascular Diseases trials

The registry lists 20 Cardiovascular Diseases studies with Abbott as lead sponsor. 4 are open to participants now and 9 have results posted.

Phase 3 2Phase 4 2No phase 16(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Navitor Japan StudyRecruitingNCT07193888
• Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart FailureRecruitingNCT06526195Not applicable
• Post-Market Clinical Follow Up Study With Navitor ValveRecruitingNCT06008080
• ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve ImplantationEnrolling by invitationNCT05932615Not applicable
• Feasibility Study of the Tendyne Mitral Valve System in Mitral Annular CalcificationCompletedNCT03539458Not applicableResults posted
• Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral RegurgitationActive, not recruitingNCT03433274Not applicableResults posted
• HeartMate 3 ELEVATE™ RegistryCompletedNCT02497950Results posted
• XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm StudyCompletedNCT01894152Results posted
• Remote Device Interrogation In The Emergency DepartmentCompletedNCT01871090Not applicableResults posted
• A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular DiseaseCompletedNCT01674712Phase 3Results posted
• A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients With DyslipidemicCompletedNCT01462877Phase 4Results posted
• Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Abnormalities in Latin AmericaCompletedNCT01200160Results posted
• ABSORB EXTEND Clinical InvestigationCompletedNCT01023789Not applicableResults posted
• Early Feasibility Study (EFS) of Abbott's Balloon-expandable (BE) TAVI System for the Treatment of Severe, Symptomatic Aortic StenosisActive, not recruitingNCT07116551Not applicable
• Early System Experience With the Abbott Balloon-expandable TAVI System: First-In-Human StudyActive, not recruitingNCT07082426Not applicable
• HeartMate 3™ LIS StudyCompletedNCT02475460Not applicable
• Remote Interrogation in Rural Emergency DepartmentsWithdrawnNCT02421549Phase 4
• A Randomized Study of the MitraClip Device in Heart Failure Patients With Clinically Significant Functional Mitral RegurgitationTerminatedNCT01772108Not applicable
• RISE: A Clinical Evaluation of the StarClose™ Vascular Closure SystemCompletedNCT00736086
• Comparison of the Combination of Fenofibrate and 40 mg Simvastatin Versus 40 mg Simvastatin MonotherapyCompletedNCT00352183Phase 3